Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
08/2000
08/10/2000WO2000046222A1 Heteroaromatic compounds with neuronal activity
08/10/2000WO2000046221A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000WO2000046220A1 Triazole and tetrazole derivatives, and their therapeutic use
08/10/2000WO2000046214A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
08/10/2000WO2000046209A1 Pyrazolecarboxylic acid derivatives, their preparation, pharmaceutical compositions containing them
08/10/2000WO2000046204A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
08/10/2000WO2000046203A2 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
08/10/2000WO2000046198A1 Anti-inflammatory indole derivatives
08/10/2000WO2000046197A1 Indole derivatives and their use as mcp-1 receptor antagonists
08/10/2000WO2000046191A1 O-thiocarbamoyl-aminoalkanol compounds, their pharmaceutically acceptable salts and process for preparing the same
08/10/2000WO2000046183A1 N-substituted amino acids, antioxidant pharmaceutical compositions containing same and methods using same
08/10/2000WO2000046181A1 Carboxylic acid derivatives, process for their preparation and their use as rotamase enzyme activity inhibitors
08/10/2000WO2000045846A1 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
08/10/2000WO2000045835A1 Vascular endothelial growth factor-2
08/10/2000WO2000045832A2 Regulation of anaesthesia
08/10/2000WO2000045818A1 Use of 3-hydroxy-3-methylglutaryl coenzym a reductase inhibitors for the manufacture of a medicament for the treatment of diabetic neuropathy
08/10/2000WO2000045815A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000WO2000045812A1 Anticonvulsant derivatives useful in treating autism
08/10/2000WO2000045807A1 Pharmaceutical composition comprising a combination of dextro- and laevo- isomers of sotalol
08/10/2000WO2000045801A2 Use of a nitrate vasodilator alone or in combination with capsaicin for the treatment of pain
08/10/2000WO2000045793A1 Ph independent extended release pharmaceutical formulation
08/10/2000WO2000045791A2 Method for controlling liposome size
08/10/2000WO2000045770A2 Compressed lecithin preparations
08/10/2000WO2000027372A8 Pharmaceutical preparations for external use containing non-steroidal anti-inflammatory and analgesic agents
08/10/2000WO2000026399A3 Method for the production of quercetin and isoquercetin derivatives
08/10/2000WO2000026251A3 A COMPLEX OF A CHAPERONE WITH ss-AMYLOID AND METHODS EMPLOYING THIS COMPLEX
08/10/2000WO2000024911A3 Human phospholipases
08/10/2000WO2000021525A3 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent
08/10/2000WO2000015206A3 Tryptophanyl ester and their n-acyl derivatives for the prevention and treatment of diseases caused or exacerbated by oxidation processes
08/10/2000WO1999066072A3 Methods for treating a neurological disease by determining bche genotype
08/10/2000WO1999063936A9 Novel therapeutic agents that modulate endothelin receptors
08/10/2000DE19906159A1 16-Hydroxyestratriene als selektiv wirksame Estrogene 16-hydroxyestratrienes as selective estrogens effective
08/10/2000DE19904710A1 Substituierte 4-Amino-2-aryl-tetrahydrochinazoline, ihre Herstellung, ihre Verwendung und sie enthaltende pharmazeutische Präparate Substituted 4-amino-2-aryl-tetrahydroquinazolines, their preparation, their use and pharmaceutical compositions containing them
08/10/2000DE19901085A1 Transdermales therapeutisches System mit einer selbstklebenden Matrix, enthaltend organische Säure-Additionssalze von Alkaloiden des Morphin- bzw. Morphinantyps Transdermal therapeutic system with a self-adhesive matrix containing organic acid-addition salts of morphine alkaloids of the or Morphinantyps
08/10/2000CA2362401A1 G-protein coupled heptahelical receptor binding compounds and methods of use thereof
08/10/2000CA2362230A1 Sulfamato hydroxamic acid metalloprotease inhibitor
08/10/2000CA2362126A1 B7rp-1 polypeptides
08/10/2000CA2361805A1 Tetrahydro isoquino linealkanol derivatives and pharmaceutical compositions containing same
08/10/2000CA2361615A1 The use of vascular endothelial growth factor 2 antagonist in the treatment of an injury to or disorder of an eye
08/10/2000CA2361551A1 Method for controlling liposome size
08/10/2000CA2361539A1 Compressed lecithin preparations
08/10/2000CA2361437A1 Pharmaceutical compositions containing nicotine or a ligand of nicotine receptors and a monamine oxydase inhibitor and their use for treating tobacco withdrawal symptoms
08/10/2000CA2361407A1 Pharmaceutical compositions
08/10/2000CA2361046A1 Methods for alleviating discomfort of a hot flash and compositions therefor
08/10/2000CA2360893A1 Tau-conotoxin peptides
08/10/2000CA2360688A1 Human t cell effectors expressing cd86 molecule and therapeutic use thereof
08/10/2000CA2360124A1 Regulation of anaesthesia
08/10/2000CA2357013A1 Anti-inflammatory indole derivatives
08/09/2000EP1026251A2 Transgenic animals expressing human P25
08/09/2000EP1026237A2 Tau/neurofilament protein kinases pk40 & pk36
08/09/2000EP1025231A1 Robo: a family of polypeptides and nucleic acids involved in nerve cell guidance
08/09/2000EP1025121A1 PEPTIDES CAPABLE OF INHIBITING THE INTERACTION BETWEEN PRESENILINS AND THE $g(b)-AMYLOID PEPTIDE OR ITS PRECURSOR
08/09/2000EP1025116A1 Estra-1,3,5(10)-triene-7alpha-thioethers
08/09/2000EP1025109A1 Benzoxazine derivatives, preparation and application in therapy
08/09/2000EP1025106A2 Allosteric adenosine receptor modulators
08/09/2000EP1025105A1 Condensed benzothiopyranic compounds
08/09/2000EP1025102A1 Bicyclic kinase inhibitors
08/09/2000EP1025101A1 Naphtho-imidazo 1,2-a]pyridine derivatives, their preparation and their use in treating central nervous system disorders
08/09/2000EP1025100A1 3-substituted tetrahydropyridopyrimidinone derivatives, method for producing the same, and their use
08/09/2000EP1025099A1 Bis-quaternary ammonium derivatives as neuromuscular relaxants
08/09/2000EP1025096A1 Substituted chroman derivatives
08/09/2000EP1025095A1 Substituted chroman derivatives
08/09/2000EP1025094A1 Substituted indan derivatives
08/09/2000EP1025091A1 Substituted pyrimidine derivatives, their preparation and their use in the treatment of neurodegenerative or neurological disorders of the central nervous system
08/09/2000EP1025087A1 Substituted isoquinoline derivatives and their use as anticonvulsants
08/09/2000EP1025082A1 Novel vitamin d derivatives with cyclopropyl rings in the lateral chains, a method and intermediate products for the production thereof and the utilization thereof for producing medicaments
08/09/2000EP1025077A1 Novel aryloxy-alkyl-dialkylamines
08/09/2000EP1024834A2 Hapten-carrier conjugates for use in drug-abuse therapy and methods for preparation of same
08/09/2000EP1024833A1 Pharmaceutical composition containing acid addition salt of basic drug
08/09/2000EP1024810A1 Method for optimizing retinal and optic nerve health
08/09/2000EP1024806A1 Use of non-immunosuppressive compounds for promoting nerve regeneration
08/09/2000EP1024802A1 (3$i(R),4$i(R))-$g(D)-TETRAHYDROCANNABINOL-11-OIC ACIDS USEFUL AS ANTIINFLAMMATORY AGENTS AND ANALGESICS
08/09/2000EP1024799A1 Method for treating disease-related or drug-induced dyskinesias
08/09/2000EP1024697A1 Method for treating alzheimer's disease
08/09/2000EP0820434B1 Phenoxyethylamine derivatives having high affinity for the 5-ht 1a receptor, preparation thereof, use thereof as drugs, and pharmaceutical compositions containing said derivatives
08/09/2000EP0764159B1 C -4 amide substituted compounds and their use as therapeutic agents
08/09/2000EP0734384B1 3-substituted 1-arylindole compounds
08/09/2000EP0642513B1 Indolocarbazole imides and their use
08/09/2000EP0623132B1 Disubstituted polycyclic systems as cognition enhancers
08/09/2000EP0539380B1 Method for the preparation and purification of a mixture of glycosphingolipids free from contamination by non-conventional viruses
08/09/2000EP0533846B1 The ciliary neurotrophic factor receptor
08/09/2000CN1262680A 6-pyrrolidin-2-ylpyrindine derivatives, their preparation and application in therapy
08/09/2000CN1262678A Triazole compounds and use thereof as dopamine-D3-ligands
08/09/2000CN1262676A 吡啶衍生物 Pyridine derivatives
08/09/2000CN1262627A Composition
08/09/2000CN1055248C Chinese patent medicine for treatment of cerebral paralysis disease
08/09/2000CN1055238C Calming and desadening pilland its preparing process
08/09/2000CN1055236C Pill for tranquilizing and curing mania and its preparing method
08/09/2000CN1055218C Full-natural health product for detoxifying cigarette and its producing method
08/09/2000CN1055217C Chinese medicine for curing dementia, dysplasia and low intelligence of child and its preparing process
08/09/2000CN1055216C Detoxifying combination for cigarette and preparation thereof
08/08/2000US6100297 Administering antioxidant cardioplegic solution during coronary bypass surgery
08/08/2000US6100289 Indole derivatives
08/08/2000US6100280 Administering a 1-(bis(fluorophenyl)alkyl)-4-(2-oxy-3-(aryl substituted amino)propyl)piperazine derivative to treat narcotic drug dependency with reduced side effects
08/08/2000US6100275 8-azabicyclo[3.2.1.]oct-2-ene derivatives, their preparation and use
08/08/2000US6100272 Tetracyclic spiro compounds as 5HT1B receptor antagonists
08/08/2000US6100271 Compounds which mediate intracellular signaling response to abnormal external stimuli characteristic of diseases; antiinflammatory agents, antifibrotic agents, antisclerotic agents, antitumor agents
08/08/2000US6100267 Enzyme inhibitor for treatment of neurodegenerative disorders, strokes, traumatic brain injury, cataracts
08/08/2000US6100266 Hydroxamic and carboxylic acid derivatives
08/08/2000US6100264 5H, 10H-imidazo [1,2-A] indeno [1,2-E] pyrazin-4-one derivatives, their preparation, their intermediates and medicaments containing them
1 ... 1491 1492 1493 1494 1495 1496 1497 1498 1499 1500 1501 1502 1503 1504 1505 1506 1507 1508 1509 1510 1511 ... 1833